COVID-19 Vaccines for Cancer Patients and Survivors: What We Know
Dana-Farber is monitoring developments in the COVID-19 vaccine process extremely closely. The current hope is that most oncology patients on active treatment will be able to receive the COVID-19 vaccine. It is believed both cancer survivors, and those who have not received immunosuppressive therapy for more than several months, will also be able to mount a successful immune response to the COVID-19 vaccine.
